Back to Authors

Barrientos, Jacqueline

Mayo Clinic

From Stanford University, Stanford (T.D.S., S.E.C.), the University of California, Irvine, Medical Center, Orange (S.O.), and Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)-Permanente Medical Group, Oakland (C.C.Z.)

Citations 1

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

New England Journal of Medicine | July 31, 2019 | Volume: 381 | Issue: 5 | Pages: 432-443

10.1056/nejmoa1817073 | PMID 31365801